Tag Archives: drug

Kyowa Kirin’s awareness message for physicians goes beyond skin-deep for Poteligeo rare cancer drug

Kyowa Kirin wants physicians to make the link between rare cancers that present on the skin to the blood connection underneath. Its new “Treat the Blood, Treat the Skin” campaign for Poteligeo, which is approved to treat two types of cutaneous lymphomas—mycosis fungoides and Sézary syndrome—is built on the insight that physicians often think of them as diseases… Read More »

Wonder drug that stops breast cancer returning after treatment could save lives

Here’s some great news – a drug has been developed that cuts the likelihood of ­hereditary breast cancer caused by BRCA1 and BRCA2 genes coming back after treatment. The results show how the drug reduces the risk of recurrence, second cancers and death by 42%. The findings were so persuasive and clear that the trial… Read More »

Albireo’s rare liver disease drug Bylvay scores back-to-back approvals in U.S., Europe

With a pair of approvals on both sides of the Atlantic, liver disease-focused biotech Albireo is off and running with its new medicine Bylvay. The oral drug, the first treatment for pruritus in patients with progressive familial intrahepatic cholestasis (PFIC), scored an FDA nod Tuesday and a European approval Monday. With the FDA’s blessing, Albireo is kicking off an “immediate”… Read More »